In addition to the development of new drug substances further options for improving the quality of life of patients are offered by innovative formulations of known APIs (active pharmaceutical ingredients). Therefore, SANOCHEMIA engages in this so-called life cycle management of proven substances. The main advantage of this approach is that an improved efficacy of the new drug formulations is only accompanied by minor regulatory risks and has less development costs. |
|
| |
